Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01923584 · ClinicalTrials.gov registry record · Phase 2
A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease
A Phase 2 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT01923584 is a Phase 2 study that has completed, run by University of South Florida. The registered enrollment target is 15 participants.
The verdict
NCT01923584, a Phase 2 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of EPI-743 in patients with Parkinson's disease.
Interventions
- DRUG EPI-743 400mg
- DRUG EPI-743 200mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01923584
The ClinicalTrials.gov registry entry for NCT01923584 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EPI-743 400mg is the first listed.
NCT01923584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01923584 about?
NCT01923584 is a clinical study titled "A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease". The purpose of this study is to evaluate the effects of EPI-743 in patients with Parkinson's disease.
What is the current status of trial NCT01923584?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2013-09. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01923584?
The interventions under investigation include: EPI-743 400mg (DRUG), EPI-743 200mg (DRUG).
Who is sponsoring clinical trial NCT01923584?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.